{"nct_id":"NCT04280328","title":"Study of Ciforadenant in Combination With Daratumumab in Patients With Relapsed or Refractory Multiple Myeloma","status":"COMPLETED","status_verified_date":"2022-03","start_date":"2020-02-20","start_date_type":"ACTUAL","primary_completion_date":"2021-09-21","primary_completion_date_type":"ACTUAL","completion_date":"2022-03-01","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["CRVS"]}